PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28560068-8	2017	The HDAC inhibitor mocetinostat showed anti-tumor effects in HDAC2-overexpressing basal-like breast cancer lines in vitro.	mocetinostat	19-31	histone deacetylase 2	Homo sapiens	61-66	
18413790-4	2008	We have developed an isotype-selective HDAC inhibitor, MGCD0103, which potently targets human HDAC1 but also has inhibitory activity against HDAC2, HDAC3, and HDAC11 in vitro.	mocetinostat	55-63	histone deacetylase 2	Homo sapiens	141-146	
22818799-3	2012	More complex second generation HDACIs undergoing clinical trials, such as the benzamide group compounds MS-275 and MGCD0103, are specific primarily for HDAC1 and HDAC2.	mocetinostat	115-123	histone deacetylase 2	Homo sapiens	162-167